Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 36 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review.
Mansilla-Polo M, Morgado-Carrasco D
Dermatol Ther (Heidelb), 14(8):1983-2038, 16 Jul 2024
Cited by: 0 articles | PMID: 39014279 | PMCID: PMC11333430
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Targeted therapy for immune mediated skin diseases. What should a dermatologist know?
López E, Cabrera R, Lecaros C
An Bras Dermatol, 99(4):546-567, 22 Mar 2024
Cited by: 0 articles | PMID: 38521706 | PMCID: PMC11221168
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Infections in the era of immunobiologicals.
Romiti R, Hirayama ALDS, Porro AM, Gonçalves HS, Miot LDB, Durães SMB, Marques SA
An Bras Dermatol, 99(2):167-180, 17 Jan 2024
Cited by: 0 articles | PMID: 38238209 | PMCID: PMC10943328
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective.
Guglielmo A, Deotto ML, Naldi L, Stinco G, Pileri A, Piraccini BM, Fortina AB, Sechi A
Dermatol Reports, 16(2):9839, 13 Sep 2023
Cited by: 0 articles | PMID: 38957642 | PMCID: PMC11216152
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials.
Stein Gold L, Thaçi D, Thyssen JP, Gooderham M, Laquer V, Moore A, Natalie CR, Zhao F, Meskimen E, Elmaraghy H, Montmayeur S, Gallo G, Jimenez G, de Bruin-Weller M
Am J Clin Dermatol, 24(4):595-607, 17 May 2023
Cited by: 6 articles | PMID: 37195407 | PMCID: PMC10191071
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Optimal Use of Jak Inhibitors and Biologics for Atopic Dermatitis on the Basis of the Current Evidence.
Kamata M, Tada Y
JID Innov, 3(3):100195, 24 Feb 2023
Cited by: 14 articles | PMID: 37180768 | PMCID: PMC10173000
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Case report: Dupilumab leads to an increased chance of head and neck Staphylococcus aureus infection in atopic dermatitis patients.
Chen M, Gao K, Ali K, Shan J, Qiu Y, Xie T, Yu Y, Wu L
Front Med (Lausanne), 10:1027589, 08 Mar 2023
Cited by: 0 articles | PMID: 36968828 | PMCID: PMC10031056
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Secondary immunodeficiencies and infectious considerations of biologic immunomodulatory therapies.
Cannon L, Pan A, Kovalick L, Sarkissian A, Wu EY
Ann Allergy Asthma Immunol, 130(6):718-726, 18 Feb 2023
Cited by: 1 article | PMID: 36801438 | PMCID: PMC10247415
Add to export list Review Free full text in Europe PMC
Corneal Refractive Surgery Considerations in Patients on Dupilumab.
Moshirfar M, Seitz T, Ply B, Ronquillo YC, Hoopes PC
J Clin Med, 11(12):3273, 08 Jun 2022
Cited by: 0 articles | PMID: 35743344 | PMCID: PMC9225227
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Genetics of Eczema Herpeticum.
Hodara E, Ong PY
Clin Rev Allergy Immunol, 63(3):390-397, 17 Sep 2022
Cited by: 2 articles | PMID: 36114947
Add to export list Review
Herpes Simplex Virus 1 Can Bypass Impaired Epidermal Barriers upon Ex Vivo Infection of Skin from Atopic Dermatitis Patients.
Möckel M, De La Cruz NC, Rübsam M, Wirtz L, Tantcheva-Poor I, Malter W, Zinser M, Bieber T, Knebel-Mörsdorf D
J Virol, 96(17):e0086422, 15 Aug 2022
Cited by: 6 articles | PMID: 35969080 | PMCID: PMC9472615
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Association of Childhood Atopic Dermatitis with Extracutaneous Infections Based on the Nationwide Cross-Sectional Study in Korea.
Park HJ, Choi M
Ann Dermatol, 34(4):315-317, 01 Aug 2022
Cited by: 0 articles | PMID: 35948338 | PMCID: PMC9365646
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Atopic dermatitis: Is innate or adaptive immunity in control? A clinical perspective.
Ong PY
Front Immunol, 13:943640, 27 Jul 2022
Cited by: 6 articles | PMID: 35967329 | PMCID: PMC9363562
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.
Nettis E, Brussino L, Patella V, Bonzano L, Detoraki A, Di Leo E, Sirufo MM, Caruso C, Lodi Rizzini F, Conte M, Yacoub MR, Triggiani M, Ridolo E, Macchia L, Rolla G, Brancaccio R, De Paulis A, Spadaro G, Di Bona D, [...] Canonica GW
Clin Mol Allergy, 20(1):6, 19 May 2022
Cited by: 16 articles | PMID: 35590407 | PMCID: PMC9121619
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
[Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?]
Traidl S, Heratizadeh A
Dermatologie (Heidelb), 73(7):529-537, 01 Jun 2022
Cited by: 0 articles | PMID: 35648139
Add to export list Review
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis.
Drucker AM, Morra DE, Prieto-Merino D, Ellis AG, Yiu ZZN, Rochwerg B, Di Giorgio S, Arents BWM, Burton T, Spuls PI, Schmitt J, Flohr C
JAMA Dermatol, 158(5):523-532, 01 May 2022
Cited by: 44 articles | PMID: 35293977 | PMCID: PMC8928094
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Atopic Eczema: Pathophysiological Findings as the Beginning of a New Era of Therapeutic Options.
Traidl S, Werfel T, Traidl-Hoffmann C
Handb Exp Pharmacol, 268:101-115, 01 Jan 2022
Cited by: 4 articles | PMID: 34236520
Add to export list
Dupilumab Therapy Improves Stratum Corneum Hydration and Skin Dysbiosis in Patients With Atopic Dermatitis.
Lee SJ, Kim SE, Shin KO, Park K, Lee SE
Allergy Asthma Immunol Res, 13(5):762-775, 01 Sep 2021
Cited by: 14 articles | PMID: 34486260 | PMCID: PMC8419647
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Practical Management of Patients with Atopic Dermatitis on Dupilumab.
Papp KA, Hong CH, Lansang MP, Turchin I, Adam DN, Beecker JR, Bissonnette R, Gooderham MJ, Jack C, Joseph M, Lynde CW, Shear NH
Dermatol Ther (Heidelb), 11(5):1805-1828, 11 Sep 2021
Cited by: 2 articles | PMID: 34510403 | PMCID: PMC8435113
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.
Kamata M, Tada Y
JID Innov, 1(3):100042, 30 Jul 2021
Cited by: 19 articles | PMID: 34909737 | PMCID: PMC8659403
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Biologics for atopic diseases: Indication, side effect management, and new developments.
Jappe U, Beckert H, Bergmann KC, Gülsen A, Klimek L, Philipp S, Pickert J, Rauber-Ellinghaus MM, Renz H, Taube C, Treudler R, Wagenmann M, Werfel T, Worm M, Zuberbier T
Allergol Select, 5:1-25, 05 Jan 2021
Cited by: 9 articles | PMID: 33426426 | PMCID: PMC7787364
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis.
Ferrucci S, Tavecchio S, Veraldi S, Berti E, Benzecry V
Acta Derm Venereol, 100(14):adv00207, 02 Jul 2020
Cited by: 3 articles | PMID: 32556344 | PMCID: PMC9199923
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The infectious complications of atopic dermatitis.
Wang V, Boguniewicz J, Boguniewicz M, Ong PY
Ann Allergy Asthma Immunol, 126(1):3-12, 07 Aug 2020
Cited by: 41 articles | PMID: 32771354 | PMCID: PMC7411503
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.
Davis JS, Ferreira D, Paige E, Gedye C, Boyle M
Clin Microbiol Rev, 33(3):e00035-19, 10 Jun 2020
Cited by: 41 articles | PMID: 32522746 | PMCID: PMC7289788
Add to export list Review Free full text in Europe PMC
IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints.
Panda SK, Wigerblad G, Jiang L, Jiménez-Andrade Y, Iyer VS, Shen Y, Boddul SV, Guerreiro-Cacais AO, Raposo B, Kasza Z, Wermeling F
Proc Natl Acad Sci U S A, 117(6):3103-3113, 24 Jan 2020
Cited by: 15 articles | PMID: 31980518 | PMCID: PMC7022208
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 36 results

1 2

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review.

Targeted therapy for immune mediated skin diseases. What should a dermatologist know?

Infections in the era of immunobiologicals.

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective.

Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials.

Optimal Use of Jak Inhibitors and Biologics for Atopic Dermatitis on the Basis of the Current Evidence.

Case report: Dupilumab leads to an increased chance of head and neck Staphylococcus aureus infection in atopic dermatitis patients.

Secondary immunodeficiencies and infectious considerations of biologic immunomodulatory therapies.

Corneal Refractive Surgery Considerations in Patients on Dupilumab.

The Genetics of Eczema Herpeticum.

Herpes Simplex Virus 1 Can Bypass Impaired Epidermal Barriers upon Ex Vivo Infection of Skin from Atopic Dermatitis Patients.

Association of Childhood Atopic Dermatitis with Extracutaneous Infections Based on the Nationwide Cross-Sectional Study in Korea.

Atopic dermatitis: Is innate or adaptive immunity in control? A clinical perspective.

Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.

[Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?]

Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis.

Atopic Eczema: Pathophysiological Findings as the Beginning of a New Era of Therapeutic Options.

Dupilumab Therapy Improves Stratum Corneum Hydration and Skin Dysbiosis in Patients With Atopic Dermatitis.

Practical Management of Patients with Atopic Dermatitis on Dupilumab.

A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Biologics for atopic diseases: Indication, side effect management, and new developments.

Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis.

The infectious complications of atopic dermatitis.

Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints.

Partnerships & funding